Chiome Bioscience Inc.
4583株式会社カイオム・バイオサイエンス
Latest half-year results
First half · fiscal year to 2026-12 · filed 2026-08-13For the first half of the fiscal year to 2026-12: Revenue ¥0.3 billion (+8.7% YoY), Ordinary income ¥-0.5 billion, Net income ¥-0.5 billion.
| This period | Year on year | |
|---|---|---|
| Revenue | ¥274m | +8.7% |
| Ordinary profit | −¥482m | — |
| Net profit to owners | −¥483m | — |
From the securities report on EDINET, which states no forecast. History via /v1/companies/4583/earnings-releases.
Financials
Japan GAAP · non-consolidated · fiscal year to 2025-12-31- Revenue
- ¥593m
- Net income
- −¥983m
- ROE
- —
- Equity ratio
- 64.1%
- Dividend / share
- —
- Employees
- 49
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | ¥593m | −¥983m | ¥1,728m | ¥1,122m | — | ¥-14.47 | −¥936m |
| 2024-12-31 | ¥781m | −¥1,021m | ¥2,469m | ¥1,920m | — | ¥-17.54 | −¥1,001m |
| 2023-12-31 | ¥682m | −¥1,220m | ¥1,751m | ¥1,158m | — | ¥-24.62 | −¥1,069m |
| 2022-12-31 | ¥631m | −¥1,243m | ¥2,215m | ¥1,791m | — | ¥-28.26 | −¥1,191m |
| 2021-12-31 | ¥713m | −¥1,480m | ¥2,339m | ¥1,893m | — | ¥-36.74 | −¥1,131m |
Indicators
Computed by us from filings · fiscal year to 2025-12-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | — | — |
| Ordinary margin | -1.6672 | 0.9 |
| Equity ratio, % | 64.1 | 64.8 |
| Revenue growth | -0.2402 | 2 |
| Net income growth | 0.0372 | 39.5 |
| Operating cash flow / assets | -0.5418 | 0.6 |
Results wording balance: -0.50. Proprietary text method; it describes the wording only and does not interpret context.
Interest example: if all ¥262m of reported debt repriced by 50 basis points, a year's interest would rise by ¥1m. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.
Via /v1/companies/4583/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themSegments, votes and tender offers
Stated in EDINET filings/v1/companies/4583/votingOwnership changes
All companies →- 2026-07-08
Growth Capital Inc. cut holdings in Chiome Bioscience Inc. (4583) to 4.06% from 5.15%, below the 5% threshold.
- 2026-06-24
Growth Capital Inc. reduced holdings in Chiome Bioscience Inc. (4583) to 5.15% from 6.23%.
- 2026-06-16
Growth Capital Inc. reduced holdings in Chiome Bioscience Inc. (4583) to 6.23% from 7.29%.
- 2026-06-05
Growth Capital Inc. reduced holdings in Chiome Bioscience Inc. (4583) to 7.29% from 8.51%.
- 2026-05-26
Growth Capital Inc. reduced holdings in Chiome Bioscience Inc. (4583) to 9.57% from 10.65%.
- 2026-05-26
Holdings of Growth Capital Inc. in Chiome Bioscience Inc. (4583) moved below 10% (10.65% -> 9.57%).
- 2026-05-26
Growth Capital Inc. reduced holdings in Chiome Bioscience Inc. (4583) to 8.51% from 9.57%.
- 2026-04-21
Growth Capital Inc. reduced holdings in Chiome Bioscience Inc. (4583) to 10.65% from 11.36%.
- 2026-04-06
Growth Capital Inc. reduced holdings in Chiome Bioscience Inc. (4583) to 11.36% from 12.36%.
- 2026-03-25
Growth Capital Inc. reduced holdings in Chiome Bioscience Inc. (4583) to 12.36% from 13.19%.
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| グロース・キャピタル株式会社 | 2023-07-20 – 2026-07-01 | +7,788,200 | +11.50pt | ¥123.19 | ¥103–167 |
| ネクスト・グロース株式会社 | 2024-07-22 – 2024-11-27 | +1,100,000 | +1.62pt | — | — |
| SMBC日興証券株式会社 | 2021-11-16 – 2022-08-30 | +4,210,100 | +8.56pt | ¥168.29 | ¥163–198 |
| 株式会社 三井住友銀行 | 2021-12-09 – 2022-01-07 | 0 | 0.00pt | — | — |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4583/trades.
5% filings
Large shareholding reports on 4583| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-07-08 | Growth Capital Inc. | 4.06% | −1.09pt | pure investment |
| 2026-06-24 | Growth Capital Inc. | 5.15% | −1.08pt | pure investment |
| 2026-06-16 | Growth Capital Inc. | 6.23% | −1.06pt | pure investment |
| 2026-06-05 | Growth Capital Inc. | 7.29% | −1.22pt | pure investment |
| 2026-05-26 | Growth Capital Inc. | 9.57% | −1.08pt | pure investment |
| 2026-05-26 | Growth Capital Inc. | 8.51% | −1.06pt | pure investment |
| 2026-04-21 | Growth Capital Inc. | 10.65% | −0.71pt | pure investment |
| 2026-04-06 | Growth Capital Inc. | 11.36% | −1.00pt | pure investment |
| 2026-03-25 | Growth Capital Inc. | 12.36% | −0.83pt | pure investment |
| 2026-03-12 | Growth Capital Inc. | 13.19% | −1.10pt | pure investment |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- — issues
- Book value
- —
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 0
- Held by listed cos.
- 0
Purposes, all holdings and mutual flags via /v1/companies/4583/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2025-12-31| Shareholder | Shares | Ratio |
|---|---|---|
| individual holder | 2,150,000 | 3.14% |
| individual holder | 962,700 | 1.40% |
| individual holder | 957,500 | 1.39% |
| 楽天証券株式会社共有口 | 933,800 | 1.36% |
| individual holder | 737,200 | 1.07% |
| 日本証券金融株式会社 | 707,300 | 1.03% |
| individual holder | 687,000 | 1.00% |
| individual holder | 607,000 | 0.88% |
| individual holder | 569,500 | 0.83% |
| individual holder | 550,000 | 0.80% |
Get this as JSON
GET /v1/companies/4583
GET /v1/companies/4583/financials
GET /v1/companies/4583/details
GET /v1/companies/4583/segments
GET /v1/companies/4583/voting
GET /v1/companies/4583/tender-offers
GET /v1/companies/4583/indicators
GET /v1/companies/4583/earnings-releases
GET /v1/events?ticker=4583
GET /v1/companies/4583/trades
GET /v1/companies/4583/cross-holdings
GET /v1/companies/4583/brief